Veterinary Medicines

Kanapen 4/20 pro inj., suspensie voor injectie voor honden en katten

Authorised
  • Kanamycin sulfate
  • Benzylpenicillin procaine
  • Procaine hydrochloride
Download as PDF

Product identification

Medicine name:
Kanapen 4/20 pro inj., suspensie voor injectie voor honden en katten
Active substance:
  • Kanamycin sulfate
  • Benzylpenicillin procaine
  • Procaine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Kanamycin sulfate
    40000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Procaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 1741
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."